Allied Market Research
Upcoming Allied Market Research
Mumps Vaccine Market

Mumps Vaccine Market, by Age Group (Pediatric and Adult) and Distribution Channel (Hospitals Pharmacies, Drug Stores, and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Mar 2022 | 35 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Mumps Vaccine Market

Request Now !

Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads to death.

The first dosage of the MMR vaccine is given to babies between ages of 12 and 15 months while the second dose is given between ages of 3 and 4 years. The virus replicates in the respiratory system and spreads to others via respiratory secretions in enclosed spaces such as schools and offices via aerosolized droplets. The typical onset of symptoms, which is mainly fever, occurs 10-12 days after the infection. Individuals on immunosuppressive medications, on the other hand, should not receive MMR immunizations since the virus can proliferate and cause illnesses.

Market Scope and Structure Analysis

Report Metric


Market Size Available for Years


  Base Year Considered


  Forecast Period


  Forecast Unit

  Value (USD)

  Segments Covered

  Product Type, Application, End User, and Region

   Companies Covered

MedImmune, Johnson & Johnson Private Limited, Merck & Co., Inc., Sanofi, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Astellas Pharma India Private Limited, CSL Limited, Emergent BioSolutions Inc., and GlaxoSmithKline plc.


COVID-19 Impact Analysis

The current COVID-19 pandemic is growing and spreading at an alarming rate globally. However, the infection rate has varied widely among countries, and it is believed that this variation may be related to the immunization programme implemented in each country. For example, Gold's epidemiological research found that the frequency of COVID-19 cases is lower in nations where live virus vaccines, such as measles, mumps, rubella (MMR), are routinely administered to all age groups, including the adult population. Massive attempts are currently being made to create a vaccine against the virus in order to control the pandemic. Because of the potential difficulties in developing a new vaccine targeting SARS-CoV-2, there also is an increase in interest in repurposing existing vaccinations. As a result, COVID-19 has a favorable impact on the global mumps vaccine market.

Top Impacting Factors

  • The surge in the number of patients with the autoimmune disease increased focus on immunization programs and the increase in vaccine awareness among consumers will drive the mumps vaccine market globally. 
  • The increase in the number of cases and the prevalence of measles, mumps, and rubella (MMR) drives the mumps vaccine market.
  • The high prevalence of pneumococcal infections, stringent regulations, and patient safety are expected to drive market expansion during the forecast period.
  • Furthermore, the expansion of healthcare providers in emerging markets provides an opportunity for vaccine manufacturers that propels the market growth.
  • The increase in usage of MMR vaccination globally to prevent COVID-19 and combination vaccines drive the mumps vaccine market.
  • However, the high cost of vaccine development, a lack of information, and vaccination availability in rural areas are factors that are expected to hamper the growth of the global mumps vaccine market during the forecasted years.

Market Trends

New Product Launches to Flourish Mumps Vaccine Market

In June 2020, Merck & Co., Inc. announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation therapies for infectious diseases and cancer. The U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and Merck received merger control clearance from the Austrian Federal Competition Authority. An initial focus of this agreement is acceleration of the development of a measles vector-based SARS-CoV-2 vaccine candidate. This candidate is currently in pre-clinical development, and clinical studies are planned to start later in 2020.

Key Benefits of Report

  • This study presents the analytical depiction of the mumps vaccine along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the mumps vaccine market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the mumps vaccine market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the mumps vaccine market.
  • The report provides a detailed mumps vaccine market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Mumps Vaccine Market Report

  • Who are the leading market players active in the mumps vaccine market?
  • What current trends will influence the mumps vaccine market in the next few years?
  • What are the driving factors, restraints, and opportunities in the mumps vaccine market?

Key Market Segments

Segments Sub-segments
Age Group
  • Pediatric
  • Adult
Distribution channel
  • Hospitals Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Mumps Vaccine Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers